Julie Krop Insider Trading $AVM AMAG PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Julie Krop.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Julie Krop. Julie Krop is Chief Medical Officer in AMAG PHARMACEUTICALS INC. ($AVM) and EVP, CMO in AMAG PHARMACEUTICALS INC. ($AVM) and SVP Clinical & Regulatory, CMO in AMAG PHARMACEUTICALS INC. ($AVM) and in Aquestive Therapeutics, Inc. ($AQST).
Julie Krop in AMAG PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Julie Krop: Chief Medical Officer, EVP, CMO, SVP Clinical & Regulatory, CMO
Holdings: 73,044 shares
Latest Transaction: Mar 04 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Julie Krop in AMAG PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Payment of Exercise | F | 7.75 | 1,333 | 10,331 | 73,044 | 74.4 K to 73 K (-1.79 %) |
| Feb 25 2020 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Payment of Exercise | F | 8.84 | 1,155 | 10,210 | 81,877 | 83 K to 81.9 K (-1.39 %) |
| Feb 25 2020 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Payment of Exercise | F | 9.50 | 867 | 8,237 | 83,032 | 83.9 K to 83 K (-1.03 %) |
| May 29 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Buy | P | 9.91 | 10,000 | 99,100 | 81,399 | 71.4 K to 81.4 K (+14.01 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Option Exercise | A | 15.51 | 25,000 | 387,750 | 25,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Grant | A | 0.00 | 15,000 | 0 | 73,606 | 58.6 K to 73.6 K (+25.59 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 58,606 | 48.6 K to 58.6 K (+20.57 %) |
| Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Payment of Exercise | F | 15.51 | 869 | 13,478 | 48,606 | 49.5 K to 48.6 K (-1.76 %) |
| Jul 03 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Payment of Exercise | F | 19.85 | 2,161 | 42,896 | 49,475 | 51.6 K to 49.5 K (-4.19 %) |
| Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | EVP, CMO | Option Exercise | A | 21.00 | 22,000 | 462,000 | 22,000 | |
| Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | EVP, CMO | Payment of Exercise | F | 21.00 | 1,700 | 35,700 | 51,636 | 53.3 K to 51.6 K (-3.19 %) |
| Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | EVP, CMO | Grant | A | 0.00 | 12,000 | 0 | 53,336 | 41.3 K to 53.3 K (+29.03 %) |
| Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | EVP, CMO | Grant | A | 0.00 | 13,000 | 0 | 41,336 | 28.3 K to 41.3 K (+45.88 %) |
| Jul 14 2017 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Sell | S | 20.00 | 4,938 | 98,760 | 28,336 | 33.3 K to 28.3 K (-14.84 %) |
| Jun 05 2017 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Payment of Exercise | F | 17.90 | 2,395 | 42,871 | 33,274 | 35.7 K to 33.3 K (-6.71 %) |
| Jun 05 2017 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Payment of Exercise | F | 22.85 | 1,108 | 25,318 | 35,669 | 36.8 K to 35.7 K (-3.01 %) |
| May 02 2017 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Sell | S | 24.45 | 1,891 | 46,235 | 36,777 | 38.7 K to 36.8 K (-4.89 %) |
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Option Exercise | A | 23.75 | 20,000 | 475,000 | 20,000 | |
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Grant | A | 0.00 | 7,500 | 0 | 38,668 | 31.2 K to 38.7 K (+24.06 %) |
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Grant | A | 0.00 | 7,500 | 0 | 31,168 | 23.7 K to 31.2 K (+31.69 %) |
| Oct 20 2016 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Sell | S | 24.80 | 4,938 | 122,462 | 23,668 | 28.6 K to 23.7 K (-17.26 %) |
| Jun 02 2016 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Payment of Exercise | F | 22.13 | 2,394 | 52,979 | 28,606 | 31 K to 28.6 K (-7.72 %) |
| Mar 02 2016 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Option Exercise | A | 25.18 | 22,500 | 566,550 | 22,500 | |
| Mar 02 2016 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Grant | A | 0.00 | 9,000 | 0 | 31,000 | 22 K to 31 K (+40.91 %) |
| Jun 03 2015 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Option Exercise | A | 68.81 | 30,000 | 2,064,300 | 30,000 | |
| Jun 03 2015 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
Page: 1